Pore size-dependent immunogenic activity of mesoporous silica-based adjuvants in cancer immunotherapy

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 4, 2014, Pages 967-974

  Wang, Xiupeng ^a   Li, Xia ^a   Ito, Atsuo ^a   Sogo, Yu ^a   Ohno, Tadao ^b  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

adjuvant; immune; mesoporous silica; pore size

Indexed keywords

CELLS; CYTOLOGY; DISEASES; LIQUID NITROGEN; MESOPOROUS MATERIALS; PHOSPHATE MINERALS; TUMORS;

ADJUVANT; CANCER IMMUNOTHERAPY; DIFFERENT PORE SIZES; IMMUNE; LEWIS LUNG CARCINOMATA; MACROPHAGE-LIKE CELLS; MESOPOROUS SILICA; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS;

PORE SIZE;

ALUMINUM HYDROXIDE; APATITE; IMMUNOLOGICAL ADJUVANT; LIQUID NITROGEN; MESOPOROUS SILICA; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LEWIS CARCINOMA; MACROPHAGE CULTURE; MOUSE; NONHUMAN; PARTICLE SIZE; SURFACE PROPERTY; TH1 CELL;

ADJUVANT; IMMUNE; MESOPOROUS SILICA; PORE SIZE;

ADJUVANTS, IMMUNOLOGIC; ADSORPTION; ANIMALS; APATITES; CARCINOMA, LEWIS LUNG; CELL SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; NEOPLASMS; NIH 3T3 CELLS; NITROGEN; POROSITY; SILICON DIOXIDE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84894481659     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34783     Document Type: Article

References (39)

1. Blattman JN, Greenberg PD,. Cancer immunotherapy: A treatment for the masses. Science 2004; 305: 200-205.
2. Wack A, Rappuoli R,. Vaccinology at the beginning of the 21st century. Curr Opin Immunol 2005; 17: 411-418.
3. Kenney RT, Edelman R,. Survey of human-use adjuvants. Expert Rev Vaccines 2003; 2: 167-188.
4. Brewer JM, Conacher M, Hunter CA, Mohrs M, Brombacher F, Alexander J,. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. J Immunol 1999; 163: 6448-6454.
5. Oka H, Emori Y, Ohya O, Kobayashi N, Sasaki H, Tanaka Y, Hayashi Y, Nomoto K,. An immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis, Z-100, restores the balance of Th1/Th2 cell responses in tumor bearing mice. Immunol Lett 1999; 70: 109-117.
6. Mercuri LP, Carvalho LV, Lima FA, Quayle C, Fantini MCA, Tanaka GS, Cabrera WH, Furtado MFD, Tambourgi DV, Matos Jdo R, Jaroniec M, Sant'Anna OA,. Ordered mesoporous silica SBA-15: A new effective adjuvant to induce antibody response. Small 2006; 2: 254-256.
7. Li X, Wang XP, Sogo Y, Ohno T, Onuma K, Ito A,. Mesoporous silica-calcium phosphate-tuberculin purified protein derivative composites as an effective adjuvant for cancer immunotherapy. Adv Healthc Mater 2013; doi: 10.1002/adhm.201200149.
8. Wang X, Li X, Ito A, Sogo Y, Ohno T,. Particle-size-dependent toxicity and immunogenic activity of mesoporous silica-based adjuvants for tumor immunotherapy. Acta Biomater 2013; doi: 10.1016/j.actbio.2013.03.031.
9. Wang XP, Li X, Sogo Y, Ito A,. Simple synthesis route of mesoporous AlOOH nanofibers to enhance immune responses. RSC Adv 2013; 3: 8164-8167.
10. Vallet-Regi M, Balas F, Arcos D,. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007; 46: 7548-7558.
11. Wang XP, Ito A, Sogo Y, Li X, Oyane A,. Zinc-containing apatite layers on external fixation rods promoting cell activity. Acta Biomater 2010; 6: 962-968.
12. Wang XP, Ito A, Sogo Y, Li X, Oyane A,. Silicate-apatite composite layers on external fixation rods and in vitro evaluation using fibroblast and osteoblast. J Biomed Mater Res Part A 2010; 92A: 1181-1189.
13. Wang X, Ito A, Li X, Sogo Y, Oyane A,. Signal molecules-calcium phosphate coprecipitation and its biomedical application as a functional coating. Biofabrication 2011; 3: 022001.
14. Colilla M, Manzano M, Vallet-Regi M,. Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomed 2008; 3: 403-414.
15. Sun JM, Zhang H, Ma D, Chen YY, Bao XH, Klein-Hoffmann A, Pfander N, Su DS,. Alkanes-assisted low temperature formation of highly ordered SBA-15 with large cylindrical mesopores. Chem Commun 2005 (): 5343-5345.
16. Fan J, Yu CZ, Lei J, Zhang Q, Li TC, Tu B, Zhou WZ, Zhao DY,. Low-temperature strategy to synthesize highly ordered mesoporous silicas with very large pores. J Am Chem Soc 2005; 127: 10794-10795.
17. Anglin EJ, Schwartz MP, Ng VP, Perelman LA, Sailor MJ,. Engineering the chemistry and nanostructure of porous silicon Fabry-Perot films for loading and release of a steroid. Langmuir 2004; 20: 11264-11269.
18. Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y,. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. ACS Nano 2011; 5: 9788-9798.
19. La Flamme KE, Popat KC, Leoni L, Markiewicz E, La Tempa TJ, Roman BB, Grimes CA, Desai TA,. Biocompatibility of nanoporous alumina membranes for immunoisolation. Biomaterials 2007; 28: 2638-2645.
20. Hudson SP, Padera RF, Langer R, Kohane DS,. The biocompatibility of mesoporous silicates. Biomaterials 2008; 29: 4045-4055.
21. Masse D, Voisine C, Henry F, Cordel S, Barbieux I, Josien R, Meflah K, Gregoire M, Lieubeau B,. Increased vaccination efficiency with apoptotic cells by silica-induced, dendritic-like cells. Cancer Res 2002; 62: 1050-1056.
22. Kobatake H, Suekane T, Murakami Y, Niwa S, Okahira A, Kushida H,. Studies on hot water extract of Mycobacterium-tuberculosis.1. Structural-analyses of polysaccharides. Yakugaku Zasshi 1981; 101: 713-722.
23. Oka H, Sasaki H, Shiraishi Y, Emori Y, Yoshinaga K, Takei M,. Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis strain aoyama B, augments anti-tumor activities of X-ray irradiation against B16 melanoma in association with the improvement of type 1 T cell responses. Biol Pharm Bull 2004; 27: 82-88.
24. Sasaki H, Schmitt D, Hayashi Y, Pollard RB, Suzuki F,. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis-The importance of lymphocytes infiltrated into tumor sites. Nat Immun 1993; 12: 104-112.
25. Kobayashi M, Pollard RB, Suzuki F,. Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma. Anticancer Drugs 1997; 8: 156-163.
26. Fu K, Klibanov AM, Langer R,. Protein stability in controlled-release systems. Nat Biotechnol 2000; 18: 24-25.
27. Wang XP, Li X, Onuma K, Ito A, Sogo Y, Kosuge K, Oyane A,. Mesoporous bioactive glass coatings on stainless steel for enhanced cell activity, cytoskeletal organization and AsMg immobilization. J Mater Chem 2010; 20: 6437-6445.
28. Li X, Wang XP, Ito A, Sogo Y, Cheng K, Oyane A,. Effect of coprecipitation temperature on the properties and activity of fibroblast growth factor-2 apatite composite layer. Mater Sci Eng C 2009; 29: 216-221.
29. Wang XP, Ito A, Sogo Y, Li X, Tsurushima H, Oyane A,. Ascorbate-apatite composite and ascorbate-FGF-2-apatite composite layers formed on external fixation rods and their effects on cell activity in vitro. Acta Biomater 2009; 5: 2647-2656.
30. Autefage H, Briand-Mesange F, Cazalbou S, Drouet C, Fourmy D, Goncalves S, Salles JP, Combes C, Swider P, Rey C,. Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/beta-tricalcium phosphate porous ceramics. J Biomed Mater Res B: Appl Biomater 2009; 91: 706-715.
31. Wang XP, Ye JD, Chen L, Xiang H,. Influence of anti-washout agents on the rheological properties and injectability of a calcium phosphate cement. J Biomed Mater Res Part B: Appl Biomater 2007; 81B: 410-418.
32. Wang XP, Ye JD, Wang YJ, Wu XP, Bai B,. Control of crystallinity of hydrated products in a calcium phosphate bone cement. J Biomed Mater Res Part A 2007; 81A: 781-790.
33. Epple M, Ganesan K, Heumann R, Klesing J, Kovtun A, Neumann S, Sokolova V,. Application of calcium phosphate nanoparticles in biomedicine. J Mater Chem 2010; 20: 18-23.
34. Vallet-Regi M, Gonzalez-Calbet JM,. Calcium phosphates as substitution of bone tissues. Progr Solid State Chem 2004; 32: 1-31.
35. Gupta RK, Relyveld EH, Lindblad EB, Bizzini B, Benefraim S, Gupta CK,. Adjuvants-A balance between toxicity and adjuvanticity. Vaccine 1993; 11: 293-306.
36. Ciocca DR, Frayssinet P, Cuello-Carrion FD,. A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and selfmantigens in cancer patients. Cell Stress Chaperones 2007; 12: 33-43.
37. Berinstein NL,. Enhancing cancer vaccines with immunomodulators. Vaccine 2007; 25: B72-B88.
38. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ,. The biology of IL-12: Coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003; 14: 361-368.
39. Schoenborn JR, Wilson CB,. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007; 96: 41-101